In a recent interview, former BlackRock portfolio manager Edward Dowd expressed his concerns about the COVID-19 vaccine rollout and its potential impact on mortality rates in the United States. Dowd accused Pfizer of data fraud during the clinical trials and highlighted a rising number of deaths that he believes are linked to the vaccine. This article provides a summary of the interview and explores the unusual excess mortality rates observed in younger age groups during 2021.
Table of contentsIntroductionDowd’s Views on COVID-19 Vaccine and Data FraudRise in Mortality Rates and Peculiarities in Insurance DataExcess Mortality Rates in the US: Younger Age GroupsAlarming Number of Deaths among the Younger Age CohortConcerns about Booster Shots and Vaccine MandatesLack of Attention from Mainstream MediaImportance of Presenting Genuine FactsPotential Consequences and Conflicts of InterestWorking to Bring Attention to Excess MortalityCOVID-19 Pandemic and the Global Debt CrisisBroken Social Contract and Vaccine MandatesImpact of Biologic Threats and Immune System ResponseConclusionFAQsRelated Article’s :
Introduction
In this article, we delve into the interview with Edward Dowd, a former BlackRock portfolio manager, who shares his concerns about the COVID-19 vaccine rollout and its impact on mortality rates in the United States. Dowd’s views shed light on potential data fraud committed during the vaccine’s clinical trials and the rise in excess mortality rates, particularly among younger age groups.
Dowd’s Views on COVID-19 Vaccine and Data Fraud
According to Dowd, Pfizer committed data fraud during the COVID-19 vaccine clinical trials. He believes that the vaccine’s adverse effects are leading to a significant increase in mortality rates. Dowd backs his claims with evidence from insurance companies, CDC data, funeral home data, and disability data.
Rise in Mortality Rates and Peculiarities in Insurance Data
Dowd highlights the rise in mortality rates during the second half of 2021, causing alarming losses reported by insurance companies. He collaborated with a Wall Street volunteer who worked as an ex-insurance analyst to uncover peculiarities in the insurance data. The losses attributed to COVID-19 and indirect COVID-19 were not discussed during earnings calls, raising concerns about the vaccine’s impact.
Excess Mortality Rates in the US: Younger Age Groups
Edward Dowd draws attention to excess mortality rates in the US during 2021 and 2022, focusing on younger age groups. Excess mortality refers to deaths above the baseline mortality rate predicted by insurance companies. Dowd attributes the high number of deaths to various factors, including COVID-19, suicides, and a mysterious event that caused a significant acceleration in deaths during August, September, and October 2021.
Alarming Number of Deaths among the Younger Age Cohort
Dowd expresses concern about the unusually high number of deaths among the younger age cohort between March 2021 and February 2022. He questions the effectiveness of the vaccines and criticizes the government’s health policies, which he believes contributed to the high mortality rates. Dowd also suggests that the vaccines are no longer effective due to the emergence of new variants and the rushed emergency use authorization process.
Concerns about Booster Shots and Vaccine Mandates
Edward Dowd raises concerns about the push for booster shots and vaccine mandates. He believes that profit has become the main motive for pharmaceutical companies and warns about potential conflicts of interest. Dowd also discusses the censorship surrounding topics related to excess mortality and disability, highlighting the need for open debate and questioning.
Lack of Attention from Mainstream Media
Dowd points out the lack of attention from mainstream media regarding the vaccine’s impact on excess mortality rates. He suggests that the fusion between pharmaceutical companies,
Discover more from Randy Bock MD PC
Subscribe to get the latest posts sent to your email.
